Compound ID | 1309
Synonym(s): Tosatoxumab | AR-301
Class: Antibody (monoclonal antibody [mAb])
| Spectrum of activity: | Gram-positive |
| Details of activity: | Adjunctive therapy for VAP caused by S. aureus |
| Institute where first reported: | Aridis |
| Highest developmental phase: | Phase 3 |
| Development status: | Active |
| External links: | |
| Guide to Pharmacology: | tosatoxumab |
| Citation: | https://aridispharma.com/ar-301/ |